Fosphenytoin Sodium(CAS: 92134-98-0)

Fosphenytoin Sodium (CAS: 92134-98-0) is regulated under the GHS system for hazardous chemicals, with specific classifications for health and environmental hazards. It is also subject to registration under REACH in the European Union, and is governed by FDA and EPA regulations in the United States, ensuring safety, environmental protection, and proper handling in manufacturing and distribution.

Alternatives to Fosphenytoin Sodium (CAS: 92134-98-0) in synthesis include related anticonvulsants such as phenytoin and other sodium phenylbutyrate derivatives. Common substitute reagents include various salts and precursors used in the synthesis of antiepileptic drugs, which can offer similar or improved therapeutic properties while potentially reducing adverse effects.

The market for Fosphenytoin Sodium (CAS: 92134-98-0) is seeing growth due to its efficacy in treating seizures, particularly in pediatric and adult patients. Research trends include development of its prodrug form for better absorption and reduced side effects, as well as exploring its potential in other neurological conditions. Market dynamics include increasing demand in developing countries and advancements in drug delivery systems.

Waste containing Fosphenytoin Sodium (CAS: 92134-98-0) should be collected in appropriate containers, sealed, and stored separately. For disposal, professional waste management services should be utilized, adhering to local environmental regulations. Incineration is a common method, but care must be taken to ensure proper combustion to minimize environmental impact. Always follow local and international environmental protection guidelines to ensure safe disposal.